PetMed Express announces routine board transition and vacancy
TipRanks' Prime Week Sale - 70% Off
- Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
- Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.
The latest update is out from Petmed Express ( (PETS) ).
On June 23, 2026, PetMed Express, Inc. announced that board member Leah A. Solivan has decided not to stand for reelection at the company’s 2026 annual meeting of stockholders, scheduled for August 11, 2026. She will continue to serve on the board until that meeting, and the company stated that her decision is not due to any disagreement regarding its operations, policies or practices, signaling a routine governance transition rather than a sign of internal conflict.
The departure of Ms. Solivan at the end of her current term will create a board vacancy that may prompt adjustments in PetMed Express’s governance structure or director composition. While the announcement does not indicate any immediate strategic shift, it may draw investor attention to upcoming board appointments and the company’s ongoing approach to oversight and leadership continuity.
The most recent analyst rating on (PETS) stock is a Sell
with a $3.00 price target.
To see the full list of analyst forecasts on Petmed Express stock,
see the PETS Stock Forecast page.
Spark’s Take on PETS Stock
According to Spark, TipRanks’ AI Analyst, PETS is a Neutral.
The score is primarily weighed down by severe financial deterioration (large FY2026 loss and sharply negative operating/free cash flow) and a strong downtrend in the stock price versus key moving averages. Offsetting factors include a debt-free balance sheet with meaningful cash and management’s reported progress on cost controls, controls remediation, and early signs of operational stabilization, but these are not yet reflected in sustained revenue/EBITDA recovery.
To see Spark’s full report on PETS stock,
click here.
More about Petmed Express
PetMed Express, Inc. operates in the pet health and wellness industry, providing prescription and non-prescription medications and related products for companion animals. The company focuses on serving pet owners through direct-to-consumer channels, positioning itself as a convenient provider of veterinary pharmaceuticals and supplies.
Average Trading Volume: 115,184
Technical Sentiment Signal: Sell
Current Market Cap: $37.82M
For detailed information about PETS stock, go to TipRanks’ Stock Analysis page.
